The contribution of small animal positron emission tomography to the neurosciences - A critical evaluation

Reviews in the Neurosciences

Volumn 15, Issue 2, 2004, Pages 131-156

  Nikolaus, Susanne ^a   Beu, Markus ^a   Wirrwar, Andreas ^a   Vosberg, Henning ^a   Müller, Hans Wilhelm ^a   Larisch, Rolf ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Animal models; Cerebral blood flow; Glucose consumption; Positron emission tomography; Receptor imaging; Transporter imaging

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID ISOPROPYL ESTER; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; FLUORODEOXYGLUCOSE F 18; GLUCOSE; MEPENZOLATE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN PERFUSION; CONTRAST ENHANCEMENT; DEPRESSION; DOPAMINERGIC SYSTEM; ENERGY METABOLISM; EPILEPSY; GLUCOSE METABOLISM; HUNTINGTON CHOREA; IMAGE RECONSTRUCTION; IMAGING SYSTEM; ISOTOPE LABELING; LEARNING; MEDICAL RESEARCH; MEMORY; NEUROSCIENCE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; STROKE;

EID: 3042700103     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.2004.15.2.131     Document Type: Review

References (113)

1. Akiyama H, McGeer PL. Microglial response to 6-hydroxydopamine-induced substantia nigra lesions. Brain Res 1989; 489: 247-253.
2. 11C]-raclopride. Ann NY Acad Sci 1993; 695: 81-85.
3. 2 receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease. Exp Neurol 2000; 166: 287-297.
4. Arendt T, Schugens MM, Marchbanks RM. Reversible inhibition of acetylcholine synthesis and behavioral effects caused by 3-bromopyruvate. J Neurochem 1990; 55: 1474-1479.
5. Beal MF. Neurochemistry and toxin models in Huntington's disease. Curr Opin Neurol 1994; 7: 542-547.
6. Björklund LM, Sanchez-Pernaute R, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 2002; 99: 2344-2349.
7. Blier P, Bergeron R. The use of pindolol to potentiate antidepressant medication. J Clin Psychiatry 1998; 59 (Suppl 5): 16-23.
8. Bloomfield PM, Rajeswaran S, Spinks TJ, et al. The design and physical characteristics of a small animal positron emission tomograph. Phys Med Biol 1995; 40: 1105-1126.
9. Brownell AL, Kano M, McKinstry RC, Moskowitz MA, Rosen BR, Brownell GL. PET and MR studies of experimental focal stroke. J Comput Assist Tomogr 1991; 15: 376-380.
10. Brownell AL, Hantraye P, Wullner U, et al. PET- and MRI-based assessment of glucose utilization, dopamine receptor binding, and hemodynamic changes after lesions to the caudate-putamen in primates. Exp Neurol 1994; 125: 41-51.
11. Brownell AL, Livni E, Galpern W, Isacson W. In vivo PET imaging in rat of dopamine terminals reveals functional neural transplants. Ann Neurol 1998; 43: 387-390.
12. Brownell GL, Burnham CA, Sterns CW, Chesler DA, Brownell AL, Palmer MR. Developments in high-resolution positron emission tomography at MGH. Intern J Imag Sys Technol 1989; 1: 207-217.
13. Chatziioannou A, Tai YC, Doshi N, Cherry SR. Detector development for microPET II: a 1 γl resolution PET scanner for small animal imaging. Phys Med Biol 2001; 46: 2899-2910.
14. Chatziioannou AF. Molecular imaging of small animals with dedicated PET tomographs. Eur J Nucl Med Mol Imaging 2002; 29: 98-114.
15. Chen YCI, Galpern WR, Brownell AL, et al. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn Reson Med 1997; 38: 389-398.
16. Chen YI, Brownell AL, Galpern W, et al. Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioral assessment. NeuroReport 1999; 10: 2881-2886.
17. Cherry SR, Yiping S, Siegel S, et al. Optical fiber readout of scintillator arrays using a multi-channel PMT: a high resolution PET detector for animal imaging. IEEE Trans Nucl Sci 1996; 43: 1932-1937.
18. 18F]-FDG. Phytother Res 1997; 11: 437-440.
19. Cicchetti F, Brownell AL, Williams K, Chen YI, Livni E, Isacson O. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci 2002; 15: 991-998.
20. Crosby G, Crane AM, Sokoloff L. Local changes in cerebral glucose utilization during ketamine anesthesia. Anesthesiology 1982; 56: 437-443.
21. Deacon T, Dinsmore J, Costantini LC, Ratliff J, Isacson O. Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation. Exp Neurol 1998; 149: 28-41.
22. Defrise M. A short reader's guide to 3D tomographic reconstruction. Comput Med Imaging Graph 2001; 25: 113-116.
23. de la Torre JC, Fortin T, Park GAS, et al. Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats. Brain Res 1992; 582: 186-195.
24. Dietrich WD, Ginsberg MD, Busto R, Smith DW. Metabolic alterations in rat somatosensory cortex following unilateral vibrissal removal. J Neurosci 1985; 5: 874-880.
25. Eklof B, Siesjo BK. the effect of bilateral carotid artery ligation upon the blood flow and the energy state of the rat brain. Acta Physiol Scand 1972; 86: 155-165.
26. Elfving B, Björnholm B, Knudsen GM. Interference of anaesthetics with radioligand binding in neuroreceptor studies. Eur J Nucl Med Mol Imaging 2003; 30: 912-915.
27. 2 receptors in the neostriatum. Brain Res 1992; 595: 124-130.
28. Fricker RA, Torres EM, Dunnett SB. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. I. Morphological characteristics. Neuroscience 1997; 79: 695-710.
29. Fricker RA, Torres EM, Hume SP, et al. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. II. Correlation between positron emission tomography and reaching behaviour. Neuroscience 1997; 79: 711-721.
30. Fricker-Gates RA, Lundberg C, Dunnett SB. Neural transplantation: restoring complex circuity in the striatum. Restor Neurol Neurosci 2001; 19: 110-138.
31. Fukuyama H, Ogawa M, Yamauchi H, et al. Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J Nucl Med 1994; 35: 1-6.
32. Fukuyama H, Hayashi T, Katsumi Y, Tsukada H, Shibasaki H. Issues in measuring glucose metabolism of rat brain using PET: the effect of the Harderian glands on the frontal lobe. Neurosci Lett 1998; 255: 99-102.
33. Glasier MM, Janis LS, Stein DG, Persistent short term memory deficits in Hebb-William maze performance are shown by rats with unilateral entorhinal cortex lesions. Behav Neurosci 1997; 111: 225-228.
34. Glass M, Dragunow M, Faull RL. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience 2000; 97: 505-519.
35. Hashitani T, Mizukawa K, Kumazaki M, Nishino H. Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts. Neurosci Res 1998; 30: 43-52.
36. Hayakawa N, Uemura K, Ishiwata K, et al. A PET-MRI registration technique for PET studies in the rat brain. Nucl Med Biol 2000; 27: 121-125.
37. Hayashi T, Fukuyama H, Katsumi Y, et al. Cerebral glucose metabolism in unilateral entorhinal cortex-lesioned rats: an animal PET study. NeuroReport 1999; 2113-2118.
38. Hirani E, Opacka-Juffry J, Gunn R, Khan I, Sharp T, Hume S. Pindolol occupancy of 5-HT(1A) receptors measured in vivo using small animal emission tomography with carbon-11 labeled WAY10065. Synapse 2000; 36: 330-341.
39. 14C]2-deoxy-D-glucose autoradiography. J Cereb Blood Flow Metab 1996; 16: 134-146.
40. 11C]-raclopride binding in rat striatum quantified using PET. Synapse 1995; 21: 45-53.
41. Hume SP, Lammertsma AA, Myers R, et al. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease. J Neurosci Meth 1996; 67: 103-112.
42. Hume SP, Gunn RN, Jones T. Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals. Eur J Nucl Med Mol Imaging 1998; 25: 173-176.
43. 1A receptors in rat brain, assessed using in vivo microdialysis and PET after fenfluramine. Synapse 2001; 41: 150-159.
44. 2 receptor cDNA into rat striatum. Brain Res Mol Brain Res 1995; 34: 315-320.
45. Insausti R, Herrero MT, Witter MP. Entorhinal cortex of the rat: cytoarchitectonic subdivisions and the origin and distribution of cortical efferents. Hippocampus 1997; 7: 146-183.
46. 11C]N-methylspiperone, in rats. Ann Nucl Med 1999; 13: 161-167.
47. 11C]KF18446 PET in the rat brain after quinolinic acid lesion: comparison with the dopamine receptor imaging. Ann Nucl Med 2002; 16: 467-475.
48. 11C]N-methylspiperone. Nucl Med Biol 2002; 29: 307-316.
49. Jeavons AP, Chandler RA, Dettmar CAR. A 3D HIDAC-PET camera with sub-millimetre resolution for imaging small animals. IEEE Trans Nucl Sci 1999; 46: 468-473.
50. Johnson SW, North RA. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 1992; 12: 483-488.
51. Katsumi Y, Hanakawa T, Fukuyama H, et al. The effect of sequential lesioning in the basal forebrain on cerebral cortical glucose metabolism in rats. An animal positron emission tomography study. Brain Res 1999; 837: 75-82.
52. 11C]CFT binding in the striatal dopamine transporters in the Fischer 344 rats: a PET study. Ann Nucl Med 2003; 17: 249-253.
53. Kety SS. Measurement of local blood flow by the exchange of an inert diffusible substance. Meth Med Res 1960; 8: 228-236.
54. Kornblum HI, Araujo DM, Annala AJ, Tatsukawa KJ, Phelps ME, Cherry SR. In vivo imaging of neuronal activation and plasticity in the rat brain with microPET, a novel high-resolution positron emission tomograph. Nat Biotechnol 2000; 18: 655-660.
55. Kuge Y, Minematsu K, Hasegawa Y, et al. Positron emission tomography for quantitative determination of glucose metabolism in normal and ischemic brains in rats: an insoluble problem by the Harderian glands. J Cereb Blood Flow Metab 1997; 17: 116-120.
56. Levivier M, Holemans S, Togasaki DM, Maloteaux JM, Brotchi J, Przedborski S. Quantitative assessment of quinolinic acid-induced striatal toxicity in rats using radioligand binding assays. Neurol Res 1994; 16: 194-200.
57. London ED, McKinney M, Dam M, Ellis A, Coyle JT. Decreased cortical glucose utilization after ibotenate lesion of the rat ventromedial globus pallidus. J Cereb Blood Flow Metab 1984; 4: 381-390.
58. MacLaren DC, Toyokuni T, Cherry SR. PET imaging of transgene expression. Biol Psychiatry 2000; 48: 337-348.
59. 2 receptor binding after chronic binge cocaine: a positron emission tomography study in rats. Neuropsychopharmacology 1998; 19: 146-153.
60. Moore TH, Osteen TL, Chatziioannou TF, Hovda DA, Cherry TR. Quantitative assessment of longitudinal metabolic changes in vivo after traumatic brain injury in the adult rat using FDG-microPET. J Cereb Blood Flow Metab 2000; 20: 1492-1501.
61. Nedergaard M, Jakobsen J, Diemer NH. Autoradiographic determination of cerebral glucose content, blood flow, and glucose utilization in focal ischemia of the rat brain: influence of the plasma glucose concentration. J Cereb Blood Flow Metab 1988; 8: 100-108.
62. Nguyen TV, Brownell AL, Chen YCI, et al. Detection of the effects of dopamine receptor sensitivity using pharmacological MRI and correlations with PET. Synapse 2000; 36: 57-65.
63. Nicoletti F, Casabona G, Genazzani AA, et al. Excitatory amino acids and neuronal plasticity: modulation of AMPA receptors as a novel substrate for the action of nootropic drugs. Funct Neurol 1992; 7: 413-422.
64. Nikkhah G, Brandis A. Neurotransplantation in Parkinson disease: experimental and clinical results of functional reconstruction of the dopaminergic system. Zentralbl Neurochir 1995; 56: 253-160.
65. Nikolaus S, Huston JP, Körber B, Thiel C, Schwarting RKW. Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesion. Peptides 1997; 18: 1161-1168.
66. 18F](3-N-methyl)benperidol. J Nucl Med 2001; 42: 1691-1696.
67. Nikolaus S, Wirrwar A, Klimke A, et al. State-of-the-art in high-resolution imaging of small animals with PET and SPECT. In: Mohan RM, ed. Research Advances in Nuclear Medicine. Kerala, India: Global Research Networks, 2002; 1: 13-29.
68. 2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET. Eur J Nucl Med Mol Imaging 2003; 30: 390-395.
69. 18F-(3-N-methyl) benperidol in the rat striatum with a PET system for small laboratory animals. J Nucl Med 2003; 44: 618-624.
70. 2 receptor kinetics with small animal positron emission tomography. In: Conn PM, ed. Methods in Enzymology: Imaging, Vol. 385. San Diego, CA: Elsevier, in press.
71. Ogawa M, Fukuyama H, Ouchi Y, et al. Uncoupling between cortical glucose metabolism and blood flow after ibotenate lesion of the rat basal forebrain: a PET study. Neurosci Lett 1996; 204: 193-196.
72. 2 receptors in rat striatum by positron emission tomography. NeuroReport 2000; 11: 743-748.
73. 11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey. Brain Res 1994; 663: 191-198.
74. Opacka-Juffry J, Ashworth S, Hume SP, Martin D, Brooks DJ, Blunt SB. GDNF protects against 6-hydroxydopamine lesion: in vivo study with microdialysis and PET. NeuroReport 1995; 7: 348-352.
75. Opacka-Juffry J, Ashworth S, Sullivan AM, Banati RB, Blunt SB. Lack of permanent nigrostriatal dopamine deficit following 6-hydroxydopamine injection into the rat striatum. J Neural Transm 1996; 103: 1429-1434.
76. 2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET. J Neural Transm 1998; 105: 349-364.
77. Otsuka T, Wei L, Bereczki D, Acuff V, Patlak C, Fenstermacher J. Pentobarbital produces dissimilar changes in glucose influx and utilization in brain. Am J Physiol 1991; 261: 265-275.
78. Ouchi Y, Fukuyama H, Matsuzaki S, et al. Compartment analysis of cerebral glucose metabolism and in vitro glucose-metabolizing enzyme activities in the rat brain. Brain Res 1996; 706: 267-272.
79. Ouchi Y, Fukuyama H, Ogawa M, et al. Cholinergic projections from the basal forebrain and cerebral glucose metabolism in rats: a dynamic PET study. J Cereb Blood Flow Metab 1996; 16: 34-41.
80. Ouchi Y, Tsukada H, Takiuchi T, Nishiyama S, Futatsubashi M. Changes in cerebral blood flow and postsynaptic muscarinic cholinergic activity in rats with bilateral carotid artery ligation. J Nucl Med 1998; 39: 198-202.
81. Ouchi Y, Kakiuchi T, Okada H, Nishiyama S, Tsukada H. The effect of aniracetam on cerebral glucose metabolism in rats after lesioning of the basai forebrain measured by PET. J Neurol Sci 1999; 164: 7-12.
82. 18F]2-fluorodeoxyglucose: validation of method. Ann Neurol 1979; 371-388.
83. Phelps ME. The merging of biology and imaging into molecular imaging. J Nucl Med 2000; 41: 661-681.
84. Przedborski S, Levivier M, Jiang H, et al. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 1995; 67: 631-647.
85. Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanaesthetized rat. Stroke 1979; 10: 267-272.
86. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987; 237: 1219-1223.
87. 11C]-WIN 35,428 and microPET. J Nucl Med 1999; 40; 261.
88. Sarter M, Bruno JP. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res Brain Res Rev 1997; 23: 28-46.
89. Sasaki T, Wakai S, Asano T, Watanabe T, Kirino T, Sano K. The effect of a lipid hydroperoxide of arachidonic acid on the canine basilar artery. An experimental study on cerebral vasospasm. J Neurosurg 1981; 54: 357-365.
90. Schwarting RKW, Huston JP. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog Neurobiol 1996; 49: 215-266.
91. Schwarting RKW, Huston JP. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 1996; 50: 275-331.
92. Seeman P, Grigoriadis D. Dopamine receptors in brain and periphery. Neurochem Int 1987; 10: 1-25.
93. Slifstein M, Laruelle M. Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl Med Biol 2001; 28: 595-608.
94. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure and normal values in the conscious and anaesthetized albino rat. J Neurochem 1977; 28: 897-916.
95. Staunton DA, Wolfe BB, Groves PM, Molinoff PB. Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior. Brain Res 1981; 211: 315-327.
96. Sullivan AM, Opacka-Juffry J, Blunt SB. Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo. Eur J Neurosci 1998; 10: 57-63.
97. 1-like and receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography. Synapse 2001; 41: 285-293.
98. Ter-Pogossian MM, Eichling JO, Davis DDO, et al. The determination of regional cerebral blood flow by means of water labeled with radioactive oxygen 15. Radiology 1969; 93: 31-40.
99. Ter-Pogossian MM, Herscovitch P. Radioactive oxygen-15 in the study of cerebral blood flow, blood volume, and oxygen metabolism. Sem Nucl Med 1985; 15: 377-394.
100. 11)C- raclopride and microPET. J Nucl Med. 2002; 43: 1570-1577.
101. Thomson JA, Marshall VS. Primate embryonic stem cells. Curr Top Dev Biol 1998; 38: 133-165.
102. Torres EM, Fricker RA, Hume SP, et al. Assessment of striatal graft viability in the rat in vivo using a small diameter PET scanner. NeuroReport 1995; 6: 2017-2021.
103. 2 receptors in the rat brain: an in vivo study using positron emission tomography. J Neurosci 1996; 16: 7670-7677.
104. Tsukada H, Nishiyama S, Kakiuchi T, et al. Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain Brain Res 1999; 849: 85-96.
105. 2 receptor into rat striatum. NeuroReport 1997; 8: 3553-3558.
106. 2 receptors in the rat striatum by positron emission tomography. Synapse 2002; 43: 195-200.
107. 2 dopamine receptors in rat brain. Brain Res 1997; 775: 183-188.
108. Watanabe M, Uchida H, Okada H, et al. A high resolution PET for animal studies. IEEE Trans Med Imaging 1992; 11: 577-580.
109. Weber S, Terstegge A, Herzog H, et al. The design of an animal PET: flexible geometry for achieving optimal spatial resolution or high sensitivity. IEEE Trans Med Imaging 1997; 16: 684-698.
110. Wirrwar A, Schramm N, Vosberg H, Müller-Gärtner HW. High resolution SPECT in small animal research. Rev Neurosci 2001; 12: 187-193.
111. Yamamoto S, Teng W, Nishizawa S, Kakiuchi T, Tsukada H. Improvement in cerebral blood flow and metabolism following subarachnoidal hemorrhage in response to prophylactic administration of the hydroxyl radical scavenger, AVS (±)N,N′-propylenedinicotinamide: a positron emission study in rats. J Neurosurg 2000; 92: 1009-1015.
112. Yoshino A, Hovda DA, Kawamata T, Katayama Y, Becker DP. Dynamic changes in local cerebral glucose utilization following cerebral conclusion in rats: evidence of a hyper- and subsequent hypometabolic states. Brain Res 1991; 561: 106-119.
113. Young AB, Penney JB, Starosta-Rubinstein S, et al. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol 1986; 20: 296-393.